home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Drug Shows Promise Against Lou Gehrig Disease

 
  March, 30 2004 9:29
your information resource in human molecular genetics
 
     
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig disease, causes nerve cells in the spinal cord and brain to die, eventually leading to paralysis and death. In the April issue of Nature Medicine, Linda Greensmith and colleagues describe a drug that slows the disease in a mouse model of ALS.

About 20% of hereditary cases of ALS are caused by a mutation that disrupts the heat shock response, a mechanism that protects cells from stress. The researchers found that treating mice with a similar mutation with arimoclomol, a drug that induces the expression of heat shock proteins, greatly improves muscle function in the mice and prolongs the survival of their nerve cells. The overall result was a 22% increase in the lifespan of the mice.

The authors suggest that arimoclomol and similar drugs could be used to treat ALS and related neurodegenerative disorders.

Author contact:

Linda Greensmith
University College
London, UK
Tel: +44 207 8373611 ext.4280
E-mail: l.greensmith@ion.ucl.ac.uk

Also available online.

(C) Nature Medicine press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.